Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Vasculitis affecting the blood vessels of the brain and/or spinal cord.
Biomarker and diagnostic research for central nervous system vasculitis has been reported in the published literature.
3 clinical trials registered, 2 recruiting. Interventions under study include other interventions, drug therapy, procedural interventions, and biologic therapy. Pipeline includes 1 PHASE2. Research is primarily sponsored by academic and government institutions.
69 publications have been identified in PubMed for central nervous system vasculitis. Research spans Case Report / Case Series (54%), Review / Meta-Analysis (20%), and Epidemiology / Natural History (10%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 37 |
Data assembled from 3 of 12 sources · Last updated Nov 2, 2026, 1:18 PM UTC
54%
Research summaries | 14 | 20% |
Disease patterns and progression | 7 | 10% |
Testing and diagnosis research | 5 | 7% |
Clinical study results | 3 | 4% |
Other research | 2 | 3% |
Laboratory research | 1 | 1% |
Phu A (2026). [PMID: 41947889](https://pubmed.ncbi.nlm.nih.gov/41947889/). *Arch Intern Med Res*. [Review / Meta-Analysis]
Nguyen JV (2026). [PMID: 41489860](https://pubmed.ncbi.nlm.nih.gov/41489860/). *JAMA Neurol*. [Clinical Trial Publication]
Nguyen UNT (2026). [PMID: 41503114](https://pubmed.ncbi.nlm.nih.gov/41503114/). *Radiol Case Rep*. [Case Report / Case Series]
Vallejos GB (2026). [PMID: 41505821](https://pubmed.ncbi.nlm.nih.gov/41505821/). *Mult Scler Relat Disord*. [Diagnostic / Biomarker]
Godasi R (2026). [PMID: 29494083](https://pubmed.ncbi.nlm.nih.gov/29494083/). *Unknown Journal*. [Review / Meta-Analysis]
Turna ZH (2026). [PMID: 41342788](https://pubmed.ncbi.nlm.nih.gov/41342788/). *Curr Opin Rheumatol*. [Review / Meta-Analysis]
Gokhale VS (2026). [PMID: 41992597](https://pubmed.ncbi.nlm.nih.gov/41992597/). *Ann Afr Med*. [Case Report / Case Series]
Meghashyam S (2026). [PMID: 41270340](https://pubmed.ncbi.nlm.nih.gov/41270340/). *Curr Opin Immunol*. [Review / Meta-Analysis]
Nehme A (2026). [PMID: 41212528](https://pubmed.ncbi.nlm.nih.gov/41212528/). *Rheumatology (Oxford)*. [Diagnostic / Biomarker]
Bildik O (2026). [PMID: 42100917](https://pubmed.ncbi.nlm.nih.gov/42100917/). *Neuroradiol J*. [Case Report / Case Series]
AI-curated news mentioning central nervous system vasculitis
Updated Oct 20, 2026
A recent study reveals that endothelial neo-antigen expression triggers CD8⁺ T cell-driven central nervous system vasculitis, which is further amplified by peripheral immune challenges. This research could provide insights into the mechanisms underlying CNS vasculitis.
A recent study highlights a rare presentation of mixed connective tissue disease (MCTD) as probable central nervous system vasculitis. This discovery may enhance understanding of MCTD's neurological manifestations.
A case study highlights Balamuthia mandrillaris as a rare cause of central nervous system vasculitis in a young child. This discovery emphasizes the need for awareness and further research into this pathogen's impact on neurological health.